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ABSTRACT
An 80-year old woman suffered from sudden onset of chest pain and dyspnea, and visited the emergency room. She re-
ceived stent implantation with a biolimus A9-eluting stent (Nobori® 3.0×24 mm) at a the mid-portion of the left anterior 
descending artery 5 months prior to admission. The emergency 5-month follow-up angiogram was performed under the 
impression of late stent thrombosis. The follow-up angiogram showed subtotal occlusion at the mid-portion of the left ante-
rior descending artery, which was the same segment of previous stent implantation 5 months ago. Immediately after throm-
bus aspiration with the thrombus aspiration catheter, the optical coherence tomography showed layered appearance of neo-
intimal hyperplasia and neointimal rupture within the previously stented segment. Thus, neointimal rupture within 
accelerated growth of neointimal tissue was observed within a relatively shorter period (i.e., about 5 months) after stent im-
plantation. (Korean Circ J 2011;41:409-412)
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Introduction
Implantation of 1st generation drug-eluting stents (DESs) 
has significantly reduced the incidence of restenosis and the 
need for repeat revascularization, compared to previously used 
bare-metal stents.1)2) However, increased use of DESs  has rais-
ed safety issues regarding the occurrence of stent thrombo-
sis.3)4) In the 1st generation DES, persistence of polymer even 
after complete elution of drugs may cause either hypersensi-
tivity reaction or inflammation in the stented coronary seg-
ments, and both these conditions are associated with increas-
ed risk for stent thrombosis.5) To overcome this life-threaten-
ing complication, many newly designed DESs have been de-
veloped. Compared to previous DESs, the biolimus A9-elut-
ing stent (BES, Nobori®, Terumo Corporation, Tokyo, Japan) 
has the characteristics of abluminally applied drug polymer 
matrix and biodegradable polymer (i.e., polymer degradation 
over the period of 6 to 9 months).6) We experienced a rare 
case of late stent thrombosis in patients who underwent im-
plantation of a BES and follow-up optical coherence tomog-
raphy (OCT) for investigation of late stent thrombosis. 
Case
An 80-year old woman suffered from sudden onset of ch-
est pain and dyspnea, and visited the emergency room. She 
had a history of hypertension, hyperthyroidism and major 
depressive disorder. Five months prior to admission, she visit-
ed the cardiology outpatient clinic for the further evaluation 
of syncope. The coronary computer tomography and corona-
ry angiography revealed significant stenosis at the mid-por-
tion of the left anterior descending artery (mLAD; B2, 80%, 
III, 0) (Fig. 2A) and a BES (Nobori® 3.0×24 mm) was success-
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fully deployed, without residual narrowing (Fig. 2B) at that time. 
Pulmonary congestion in both lung fields, suggestive of pul-
monary edema, was noticed on the chest X-ray; newly de-
veloped Q wave was visible at leads V1-4 on the electrocardio-
gram (Fig. 1); recent regional wall motion abnormality (i.e., 
akinesia without thinning) was detected in the left anterior de-
Fig. 1. First electrocardiogram at recorded in the emergency room; the Q wave was visible at on leads V1-4. 
Fig. 2. Pre-intervention (A) and post-intervention (B) angiographic findings in lesion of the left anterior descending artery (arrow in A) are sh-
own 5-months before the onset of late stent thrombosis. At the onset of late stent thrombosis, emergency follow-up angiogram showed sub-
total occlusion at the mid-portion of the left anterior descending artery (C). The final angiogram, performed after balloon angioplasty with a 
drug eluting balloon, showed no residual stenosis at the mid-portion of the left anterior descending artery and a jailed diagonal branch (D). 
A  
C  
B  
D  
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scending artery territory, and the left ventricular ejection frac-
tion was reduced by 30% on the echocardiogram at this time. 
Cardiac enzyme was slightly elevated (Troponin-T 0.124 ng/
mL). Emergency follow-up angiogram was performed un-
der the impression of non-ST elevation myocardial infarction, 
caused by late stent thrombosis. The follow-up angiogram 
showed subtotal occlusion at the mid-portion of the left ante-
rior descending artery, the same segment of previous stent 
implantation 5 months ago (B2, 99%, II, 0) (Fig. 2C). Imme-
diately after thrombus aspiration with the thrombus aspira-
tion catheter (Thrombuster II®, Kaneka Corp. Japan), OCT 
was performed for investigation of both morphologic featur-
es and underlying cause of late stent thrombosis. The OCT sh-
owed layered appearance of neointmal hyperplasia and neo-
intimal rupture within the previously stented segment (Fig. 3A 
and B). Considering that the stent thrombosis was not due 
to delay of stent strut endothelialization, balloon angioplasty 
with a drug eluting balloon (SeQuent please®, B. Braun Mel-
sungen AG, Germany) was successfully performed at the mid-
portion of the left anterior descending artery with no residual 
stenosis, however jailed diagonal branch (Figs. 2D and 3C). 
After the surgical procedure, she was discharged 3 days later, 
without any significant complications.
Discussion
Occurrence of stent thrombosis has been the major con-
cern after implantation of 1st generation DESs. Iakovou et al.3) 
reported 1.3% incidence of stent thrombosis in patients who 
received DES implantation. In addition, 45% of the patients 
who experienced stent thrombosis died. Daemen et al.4) also 
reported that stent thrombosis occurring within 30 days after 
DES implantation increases 0.6% annually. While occurr-
ence of acute or subacute stent thrombosis (i.e., onset of stent 
thrombosis within 30 days after stent implantation) is mainly 
related to procedural factors, development of late or very late 
stent thrombosis has different characteristics. Previous pa-
thologic studies showed that delayed stent strut endothelial-
ization and potential prothrombotic properties of the DES it-
self (i.e., persistence of polymer even after complete elution of 
drugs) are important factors that may lead to late stent throm-
bosis.7)8) A recent intravascular ultrasound study by Lee et 
al.9) showed that neointimal rupture within the stent area was 
observed in 43.5% of 23 patients with very late stent thrombo-
sis, after 1st generation DES implantation. A pathologic study 
reported that DES therapy may accelerate atherosclerosis, 
while reducing restenosis.10) Therefore, new DESs with a bio-
degradable polymer have been developed to avoid complic-
ations caused by persistence of polymer. Several studies com-
pared the outcomes (i.e., cardaic death, myocardial infarc-
tion, and stent thrombosis) of BESs with those of 1st gener-
ation DESs and concluded that BESs were not inferior to 1st 
generation DESs and that both suitable alternatives and long 
term outcomes were neeed.11)
Despite of these favorable conditions of a BESs compared 
to 1st generation DESs, accelerated neointimal proliferation, 
abnormal neointimal morphology (i.e., layered appearance of 
the neointima) and additional neointimal rupture were ob-
served in this patient with late stent thrombosis within a rel-
atively shorter period of time (i.e., about 5 months) after im-
plantation of a BES. Due to high resolution images of the OCT, 
the cause of stent thrombosis was more precisely diagnosed 
than in previous cases using IVUS or other modalities.
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